1. Home
  2. BIRK vs STVN Comparison

BIRK vs STVN Comparison

Compare BIRK & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birkenstock Holding plc

BIRK

Birkenstock Holding plc

HOLD

Current Price

$32.58

Market Cap

5.4B

Sector

N/A

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$19.61

Market Cap

5.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIRK
STVN
Founded
1774
1949
Country
United Kingdom
Italy
Employees
N/A
N/A
Industry
Containers/Packaging
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.2B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
BIRK
STVN
Price
$32.58
$19.61
Analyst Decision
Buy
Buy
Analyst Count
23
14
Target Price
★ $49.45
$24.47
AVG Volume (30 Days)
★ 1.8M
315.7K
Earning Date
08-13-2026
11-03-2026
Dividend Yield
N/A
★ 0.32%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.96
$6.96
Revenue Next Year
$13.73
$9.15
P/E Ratio
★ $17.48
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$29.93
$12.89
52 Week High
$50.73
$27.00

Technical Indicators

Market Signals
Indicator
BIRK
STVN
Relative Strength Index (RSI) 46.32 45.30
Support Level $30.53 $18.75
Resistance Level $33.86 $20.02
Average True Range (ATR) 1.20 0.64
MACD -0.03 0.03
Stochastic Oscillator 21.84 44.59

Price Performance

Historical Comparison
BIRK
STVN

About BIRK Birkenstock Holding plc

Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.

About STVN Stevanato Group S.p.A.

Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.

Share on Social Networks: